Functional analysis of rosmarinic acid synthase reveals mutations that boost catalytic efficiency, indicating potential for microbial RA production.
Rosmarinic acid (RA) has been incorporated in various nutritious and health-promoting products. Rosmarinic acid synthase (RAS) is a committed enzyme in RA biosynthesis. However, SmRASs from Salvia miltiorrhiza remains functionally uncharacterized. Herein, a group of SmRASs was identified from the S. miltiorrhiza, and recombinant SmRAS1 was demonstrated to convert caffeoyl-CoA and 3,4-dihydroxyphenyllactic acid to form RA. SmRAS1 exhibited maximum activity at 45 °C and pH 8.0 with Km values of 18 μM and 1647 μM for caffeoyl-CoA and 3,4-dihydroxyphenyllactic acid, respectively. Subsequently, three highly catalytic activity SmRAS1 mutations R367W, G293I, and G293Rwere obtained, exhibiting 1.53-2.15 fold higher catalytic efficiency than the wild-type enzyme. Structural analysis and molecular dynamics simulations revealed that enlarged substrate access tunnel and reduced flexibility of residues286-295 located above the substrate pocket enhanced its catalytic activity. These results elucidate the mechanism underlying RA biosynthesis in S. miltiorrhiza and provide a promising RAS for RA biosynthesis in microbes.
No takes yet. Share an insight, caveat, or question.
Feng et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: